Biogen’s continued focus on developing an effective alzhiemers drug reflects progress and uncertainty in the global fight against the disease
Generic Semaglutide has helped Sun Pharmaceutical Industries expand its global presence with a fresh regulatory win.
India is positioning medical research as a central pillar in its long-term strategy to achieve developed nation status by 2047
India’s healthcare system is set for a major boost through medical insurance expansion. The government is considering doubling coverage under Ayushman Bharat
COVID preparedness has become a key focus in Odisha after fresh COVID-19 cases were reported in neighboring Andhra Pradesh.
The Indian Pharma Industry is moving towards a biosimilars manufacturing growth phase. Earlier this year, India was the subject of a global collaboration that reflects growing international trust in its abilities
The Alzheimer's drug market is witnessing a significant strategic shift as Eisai and Biogen strengthen their competitive position. AS the new FDA approval allows at-home initiation of their therapy
Emcure has tightened its grip on Gennova with a Rs 231.8 crore acquisition. The deal will make Gennova a wholly owned subsidiary of the company.
A major breakthrough in the treatment of advanced rectal cancer has emerged as innovative immunotherapy drugs continue to reshape oncology
The Oxford Ebola vaccine has reached a major milestone. The University of Oxford has started the world's first human trial for a vaccine against the Bundibugyo Ebola virus.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")